In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Orthovita gets $10.8mm from financings

Executive Summary

Orthovita Inc. (bone substitutes) grossed a total of $10.86mm selling common stock at $4 per share in two private equity financings. It sold $7.9mm (1,975,000 shares at a 22% discount) to buyers led by Hambrecht & Quist Healthcare and Life Sciences Investors, followed by $2.96mm (740k shares at about a 13% discount) to Meridian Venture Partners.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

UsernamePublicRestriction

Register